Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness

Journal of Cachexia, Sarcopenia and Muscle

Volumn 8, Issue 1, 2017, Pages 89-101

  Goossens, Chloë ^a   Marques, Mirna Bastos ^a   Derde, Sarah ^a   Vander Perre, Sarah ^a   Dufour, Thomas ^a   Thiessen, Steven E ^a   Güiza, Fabian ^a   Janssens, Thomas ^a   Hermans, Greet ^a   Vanhorebeek, Ilse ^a   De Bock, Katrien ^b   Van den Berghe, Greet ^a   Langouche, Lies ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Critical illness; Metabolism; Obesity; Skeletal muscle

Indexed keywords

FATTY ACID; GLYCEROL; KETONE BODY; LIPID; TRIACYLGLYCEROL; 3 HYDROXYBUTYRIC ACID; MUSCLE PROTEIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; BODY COMPOSITION; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; FATIGUE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KETOGENESIS; LEAN TISSUE; MALE; METABOLISM; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; NUTRITION; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SKELETAL MUSCLE; WEIGHT REDUCTION; AGED; ANATOMY AND HISTOLOGY; ANIMAL; BLOOD; C57BL MOUSE; DIET RESTRICTION; FEMALE; GENETICS; LIVER; MIDDLE AGED; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PATHOLOGY; PHYSIOLOGY; QUADRICEPS FEMORIS MUSCLE; RECTUS ABDOMINIS MUSCLE;

3-HYDROXYBUTYRIC ACID; AGED; ANIMALS; BODY COMPOSITION; CRITICAL ILLNESS; FASTING; FATTY ACIDS; FEMALE; GLYCEROL; HUMANS; LIVER; MALE; MICE, INBRED C57BL; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE WEAKNESS; MUSCULAR ATROPHY; NUTRITIONAL STATUS; OVERWEIGHT; PARENTERAL NUTRITION; QUADRICEPS MUSCLE; RECTUS ABDOMINIS; SEPSIS; TRIGLYCERIDES;

EID: 84978707180     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12131     Document Type: Article

References (49)

1. Vanhorebeek I, Langouche L, Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006;2:20–31.
2. Preiser JC, van Zanten AR, Berger MM, Biolo G, Casaer MP, Doig GS, et al. Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care 2015;19:35, doi:10.1186/s13054-015-0737-8.
3. Puthucheary Z, Harridge S, Hart N. Skeletal muscle dysfunction in critical care: wasting, weakness, and rehabilitation strategies. Crit Care Med 2010;38:S676–S682.
4. Fletcher SN, Kennedy DD, Ghosh IR, Misra VP, Kiff K, Coakley JH, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003;31:1012–1016.
5. Jolley SE, Bunnell A, Hough CL. Intensive care unit acquired weakness. Chest 2016;doi:10.1016/j.chest.2016.03.045.
6. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007;33:1876–1891.
7. Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle 2010;1:147–157.
8. Derde S, Vanhorebeek I, Guiza F, Derese I, Gunst J, Fahrenkrog B, et al. Early parenteral nutrition evokes a phenotype of autophagy deficiency in liver and skeletal muscle of critically ill rabbits. Endocrinology 2012;153:2267–2276.
9. Derde S, Vanhorebeek I, Ververs EJ, Vanhees I, Darras VM, Van Herck E, et al. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits. Crit Care Med 2010;38:602–611.
10. Derde S, Hermans G, Derese I, Guiza F, Hedstrom Y, Wouters PJ, et al. Muscle atrophy and preferential loss of myosin in prolonged critically ill patients. Crit Care Med 2012;40:79–89.
11. Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA 2013;310:1591–1600.
12. Klaude M, Mori M, Tjader I, Gustafsson T, Wernerman J, Rooyackers O. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci 2012;122:133–142.
13. Hermans G, Casaer MP, Clerckx B, Guiza F, Vanhullebusch T, Derde S, et al. Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 2013;1:621–629.
14. Pickkers P, de Keizer N, Dusseljee J, Weerheijm D, van der Hoeven JG, Peek N. Body mass index is associated with hospital mortality in critically ill patients: an observational cohort study. Crit Care Med 2013;41:1878–1883.
15. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, Committee ASA, et al. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007;153:74–81.
16. Akinnusi ME, Pineda LA, El Solh AA. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008;36:151–158.
17. Hogue CW Jr, Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensive Care Med 2009;35:1152–1170.
18. Peake SL, Moran JL, Ghelani DR, Lloyd AJ, Walker MJ. The effect of obesity on 12-month survival following admission to intensive care: a prospective study. Crit Care Med 2006;34:2929–2939.
19. Abhyankar S, Leishear K, Callaghan FM, Demner-Fushman D, McDonald CJ. Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients. Crit Care 2012;16:R235, doi:10.1186/cc11903.
20. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, et al. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol 2014;64:2743–2749.
21. Mohebi R, Simforoosh A, Tohidi M, Azizi F, Hadaegh F. Obesity paradox and risk of mortality events in chronic kidney disease patients: a decade of follow-up in tehran lipid and glucose study. J Ren Nutr 2015;doi:10.1053/j.jrn.2014.12.006.
22. Lavie CJ, De Schutter A, Alpert MA, Mehra MR, Milani RV, Ventura HO. Obesity paradox, cachexia, frailty, and heart failure. Heart Fail Clin 2014;10:319–326.
23. Suneja M, Kumar AB. Obesity and perioperative acute kidney injury: a focused review. J Crit Care 2014;29:694 e1–694 e6.
24. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6 J and A/J mice. Metab Clin Exp 1995;44:645–651.
25. Marques M, Perre S, Aertgeerts A, Derde S, Guiza F, Casaer MP, et al. Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages. Crit Care 2013;17:R193, doi:10.1186/cc12887.
26. Janssens T, Antanas L, Derde S, Vanhorebeek I, Van den Berghe G, Guiza Grandas F. Charisma: an integrated approach to automatic H&E-stained skeletal muscle cell segmentation using supervised learning and novel robust clump splitting. Med Image Anal 2013;17:1206–1219.
27. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005;115:2277–2286.
28. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011;365:506–517.
29. Gayat E, Pirracchio R, Resche-Rigon M, Mebazaa A, Mary JY, Porcher R. Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Med 2010;36:1993–2003.
30. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147–152.
31. Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med 2014;370:1626–1635.
32. Fuentes EN, Ruiz P, Valdes JA, Molina A. Catabolic signaling pathways, atrogenes, and ubiquitinated proteins are regulated by the nutritional status in the muscle of the fine flounder. PLoS One 2012;7:e44256, doi:10.1371/journal.pone.0044256.
33. Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov 2015;14:58–74.
34. Jagoe RT, Lecker SH, Gomes M, Goldberg AL. Patterns of gene expression in atrophying skeletal muscles: response to food deprivation. FASEB J 2002;16:1697–1712.
35. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007;131:1149–1163.
36. Kadowaki M, Karim MR. Cytosolic LC3 ratio as a quantitative index of macroautophagy. Methods Enzymol 2009;452:199–213.
37. Puthucheary ZA, Phadke R, Rawal J, McPhail MJ, Sidhu PS, Rowlerson A, et al. Qualitative ultrasound in acute critical illness muscle wasting. Crit Care Med 2015;43:1603–1611.
38. Hill NE, Saeed S, Phadke R, Ellis MJ, Chambers D, Wilson DR, et al. Detailed characterization of a long-term rodent model of critical illness and recovery. Crit Care Med 2015;43:e84–e96.
39. Bjorntorp P, Bergman H, Varnauskas E. Plasma free fatty acid turnover rate in obesity. Acta Med Scand 1969;185:351–356.
40. Karsenty C, Ulmer M, Chanussot F, Ratanasavanh R, Debry G. Paradoxical effect of ethanol on liver lipogenesis in the genetically-obese Zucker rat. Br J Nutr 1985;54:15–20.
41. Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 1980;60:143–187.
42. Shukla SK, Gebregiworgis T, Purohit V, Chaika NV, Gunda V, Radhakrishnan P, et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab 2014;2:18, doi:10.1186/2049-3002-2-18.
43. Vanhorebeek I, Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Curr Opin Pharmacol 2004;4:621–628.
44. Ferezou J, Bach AC. Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions. Nutrition 1999;15:44–50.
45. Carpentier YA, Deckelbaum RJ. In vivo handling and metabolism of lipid emulsions. World Rev Nutr Diet 2015;112:57–62.
46. Gouni I, Oka K, Etienne J, Chan L. Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. J Lipid Res 1993;34:139–146.
47. Lanza-Jacoby S, Sedkova N, Phetteplace H, Perrotti D. Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle. J Lipid Res 1997;38:701–710.
48. Askanazi J, Carpentier YA, Elwyn DH, Nordenstrom J, Jeevanandam M, Rosenbaum SH, et al. Influence of total parenteral nutrition on fuel utilization in injury and sepsis. Ann Surg 1980;191:40–46.
49. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015. J Cachexia Sarcopenia Muscle 2015;6: 315–6.